Adia Nutrition Inc. has issued a correction regarding its recent press release dated May 16, 2025. The company successfully uplisted to the OTCQB Venture Market in a record-breaking six weeks and completed SEC Rule 15c2-11 compliance. This swift achievement reinforces Adia's commitment to transparency and operational excellence. The correction clarifies details about the uplisting and compliance, emphasizing Adia Nutrition's rapid progress and strategic milestones in the regenerative medicine sector.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.